Katarzyna
Katarzyna Badowska-Roslonek, Otwock PL
Patent application number | Description | Published |
---|---|---|
20110124866 | PROCESS FOR PREPARATION OF TADALAFIL - Process for the preparation of tadalafil of high pharmaceutical purity is characterized in that the sequence of reactions comprising acetylation of methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate with chloro acetyl chloride and cyclisation of the formed intermediate with methyl amine, is performed as a ‘one-pot’ process, without isolating the intermediate methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate. | 05-26-2011 |
Katarzyna Barycka, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20110003892 | ALL-TRANS RETINOID ESTERS AS ACTIVE PHARMACEUTICAL INGREDIENTS, ORAL AND TOPICAL DOSAGE FORM COMPOSITIONS THEREOF, AND METHODS OF TREATING SKIN CONDITIONS THEREOF - Active pharmaceutical ingredients being retinoic acid ester compounds including all- trans-retinoic acid tent-butyl ester, all-trans-retinoic acid iso-butyl ester, all-trans-retinoic acid iso-propyl ester, all-trans-retinoic acid sec-butyl ester, and, all-trans-retinoic acid 1-adamantyl ester, oral and topical dosage form compositions thereof, and methods of treating various skin conditions thereof. | 01-06-2011 |
Katarzyna Chuda, Asnieres Sur Seine FR
Patent application number | Description | Published |
---|---|---|
20130115447 | MAT OF POLYMER FIBERS CONTAINING A DIHYDRAZIDE AND USE THEREOF - The present invention relates to a mat of polymer fibers capable of trapping formaldehyde which contains at least one dihydrazide. | 05-09-2013 |
20130157028 | MAT OF POLYMER FIBERS CONTAINING AN ACETOACETAMIDE AND USE THEREOF - The present invention relates to a mat of polymer fibers capable of trapping formaldehyde which contains at least 0.5% by weight of an acetoacetamide of formula: | 06-20-2013 |
20150114545 | SELF-ADHESIVE WATER-ACTIVABLE GLASS WEB - The invention relates to a self-adhesive wall covering comprising a glass textile with a closed structure, consisting of glass fibers and of a water-permeable polymer binder, and an adhesive coating comprising both a pressure-sensitive adhesive (PSA) and a water-activable latent adhesive. The definitive attachment to the wall of this repositionable self-adhesive covering takes place, after hanging, by applying one or more coats of water-based paint. | 04-30-2015 |
Katarzyna Chuda, Paris FR
Patent application number | Description | Published |
---|---|---|
20110300359 | PAINTER'S CANVAS INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE AND MANUFACTURING PROCESS - The present invention relates to a painter's canvas based on glass fibers intended to be applied to an interior surface of a building, which includes an agent capable of trapping formaldehyde chosen from compounds comprising active methylene(s), hydrazides, tannins, amides, amino acids, peptides and proteins. | 12-08-2011 |
20120245267 | FILM-FORMING COMPOSITION INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE - The present invention relates to a film-forming composition intended to be applied to an inner surface of a building which includes an agent capable of trapping formaldehyde chosen from compounds comprising active methylene(s), tannins and amides. | 09-27-2012 |
20160024319 | FILM-FORMING COMPOSITION INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE - The present invention relates to a film-forming composition intended to be applied to an inner surface of a building which includes an agent capable of trapping formaldehyde chosen from compounds comprising active methylene(s), tannins and amides. | 01-28-2016 |
Katarzyna Chuda, Villejuif FR
Patent application number | Description | Published |
---|---|---|
20090077900 | Abrasive products including active fillers - An abrasive product comprises an abrasive component and a bond component. In one embodiment, the bond component includes a binder and a filler component that includes a cryolite and at least one member selected from the group consisting of sodium oxalate (Na | 03-26-2009 |
20120132851 | MAT OF MINERAL FIBERS INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE AND MANUFACTURING PROCESSES - The present invention relates to a mat of mineral fibers which comprises an agent capable of trapping formaldehyde present in particular in dwellings or offices and transportation vehicles. | 05-31-2012 |
20130280975 | AQUEOUS FLAME RETARDANT COMPOSITION FOR MINERAL FIBER-BASED MAT, AND MATS OBTAINED - The present invention concerns an aqueous flame retardant composition for mineral fiber-based mats, in particular glass or rock fibers, which comprises: | 10-24-2013 |
20130295361 | BINDER FOR MAT OF FIBERS, ESPECIALLY MINERAL FIBERS, AND PRODUCTS OBTAINED - The present invention concerns a binder for a mat of fibers, especially mineral fibers, which comprises: | 11-07-2013 |
20140017471 | GLASS STRAND PROVIDED WITH A POLYMER-BASED COATING AND SCREEN COMPRISING SAID STRAND - The present invention relates to a glass strand provided with a coating based on a polymer chosen from vinyl acetate/vinyl chloride copolymers, polyvinyl chloride and polyvinylidene chloride and which comprises a silane of formula Si(R | 01-16-2014 |
20140113123 | BINDER FOR MINERAL AND/OR ORGANIC FIBER MAT, AND PRODUCTS OBTAINED - The present invention concerns an aqueous binder for a fiber mat, in particular mineral fibers, which comprises, in parts by weight: | 04-24-2014 |
20140127491 | BINDER FOR MINERAL AND/OR ORGANIC FIBER MAT, AND PRODUCTS OBTAINED - The present invention concerns an aqueous binder for a fiber mat, in particular mineral fibers, which comprises, in parts by weight: | 05-08-2014 |
20150050469 | WALL COVERING FOR THERMAL AND ACOUSTIC COMFORT - A multilayer wall covering includes: (a) a support layer formed by an organic polymer foam having an open porosity of between 0.50 and 0.995, or by a viscose fiber nonwoven having a mass per unit area of between 150 g/m2 and 500 g/m2, (b) a surface layer formed by a glass textile, having a static air flow resistance, measured according to the standard ISO 9053, of between 105 N·s·m-4 and 106 N·s·m-4, (c) at the interface between the support layer (a) and the surface layer (b), a discontinuous adhesive layer having a mass per unit area of between 17 and 60 g/m2. There is also provided a process including the use of such a covering for improving both the acoustic and the thermal comfort of a room, and two processes for manufacturing such a covering. | 02-19-2015 |
20150122399 | ACOUSTIC ABSORBENT WALL COATING - A multilayer sound-absorbing covering includes (a) a support layer made of a nonwoven based on organic fibers having a tranverse multilobal cross section, (b) a surface layer formed by a glass textile, having a static air flow resistance, measured according to the standard ISO 9053, between 10 | 05-07-2015 |
Katarzyna Ciesielska, Lowicz PL
Patent application number | Description | Published |
---|---|---|
20150284761 | LACTONASE DERIVED FROM CANDIDA BOMBICOLA AND USES THEREOF - Described is an enzyme derived from | 10-08-2015 |
Katarzyna Ciesielska, Iowicz PL
Patent application number | Description | Published |
---|---|---|
20140335567 | LACTONASE DERIVED FROM CANDIDA BOMBICOLA AND USES THEREOF - The present disclosure relates to an enzyme derived from | 11-13-2014 |
Katarzyna Czapska, Meudon FR
Patent application number | Description | Published |
---|---|---|
20140365364 | METHOD OF PAYMENT FOR A PRODUCT OR A SERVICE ON A COMMERCIAL SITE THROUGH AN INTERNET CONNECTION AND A CORRESPONDING TERMINAL - The invention relates to a method of payment for a product or a service on a commercial website through an Internet connection and a terminal that is connected to the commercial website via the Internet connection, with the payment being made using at least one identifier contained in a payment card. According to the invention, the terminal comprises an interface of the NFC type that reads the aforementioned banking identifier contained in the payment card, with the payment card being of the NFC type, and the terminal having an application able to transmit the identifier to a dedicated server on a secure link which the commercial website is connected to after the identifier has been read by the terminal, with the dedicated server concatenating the payment characteristics before transmitting same to the bank site. | 12-11-2014 |
Katarzyna Dechnik, Krakow PL
Patent application number | Description | Published |
---|---|---|
20080299099 | Strain composition of the lactobacillus genus and the application of strain composition of the lactobacillus genus - A subject of the invention is a composition containing strains | 12-04-2008 |
Katarzyna Dobrosielska-Oura, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20150299404 | PROCESS FOR PRODUCING SURFACE- POSTCROSSLINKED WATER-ABSORBENT POLYMER PARTICLES - The present invention relates to a process for producing surface-postcrosslinked water-absorbent polymer particles by coating of water-absorbent polymer particles having a content of residual monomers in the range from 0.03 to 15% by weight with at least one surface-postcrosslinker and thermal surface-postcrosslinking at temperatures in the range from 100 to 180° C. | 10-22-2015 |
Katarzyna Dzierzba, Jelenia Gora PL
Patent application number | Description | Published |
---|---|---|
20140205839 | PURE ALBUMIN AND ITS METHOD OF PREPARATION AND DETECTION - The subject of the present invention is a pure monomeric bovine serum albumin, a method of producing it characterised by the use column chromatography in resin and a method of identifying it using dynamic light scattering. | 07-24-2014 |
Katarzyna Florys, Iwaniska PL
Patent application number | Description | Published |
---|---|---|
20140255343 | DNA VACCINE, METHOD OF INDUCING THE IMMUNE RESPONSE, METHOD OF IMMUNISATION, ANTIBODIES SPECIFICALLY RECOGNISING THE H5 HAEMAGGLUTININ OF AN INFLUENZA VIRUS AND USE OF THE DNA VACCINE - The object of the invention is a DNA vaccine, method of inducing the immune response, antibodies specifically recognising the haemagglutinin H5 of an influenza virus and application of the DNA vaccine. According to the invention, one or two-fold immunisation of hens with DNA vaccine containing a cDNA encoding the modified H5 haemagglutinin HA protein, i.e. with the deletion of the cleavage site between HA subunits (this provides for greater safety of the vaccines). Moreover, the encoding region of the HA is modified in such a way that protein production in the bird cells should achieve maximal yield. The main modification is codon optimisation for the hens and deletion of the site of proteolytic cleavage between subunits HA1 and HA2. | 09-11-2014 |
Katarzyna Garbat, Nieprei PL
Patent application number | Description | Published |
---|---|---|
20130020532 | Liquid crystal carbonate and liquid crystal medium containing the same with positive or negative dielectric anisotropy - A novel liquid crystalline carbonate and the mixture containing the same: | 01-24-2013 |
Katarzyna Gorna, Pabianice PL
Patent application number | Description | Published |
---|---|---|
20100048791 | SPHERICAL CALCIUM CARBONATE PARTICLES - Disclosed are spherical calcium carbonate particles that have an average diameter ranging from 0.05 μm to 2.0 μm and a maximum water content of 5.0 percent by weight relative to the total weight thereof. Said calcium carbonate particles are preferably obtained by reacting calcium chloride with dialkyl carbonate in the presence of an alkali metal hydroxide in aqueous solution. The components are advantageously used at the following concentrations: a) CaCl | 02-25-2010 |
Katarzyna Gorna, Vienna AT
Patent application number | Description | Published |
---|---|---|
20100233269 | MINERALIZED POLYMER PARTICLES AND THE METHOD FOR THEIR PRODUCTION - A process for mineralizing a particulate organic material includes providing particles of a non-porous, swellable organic material, and contacting the particles with a solution containing at least one cation and a solution containing at least one anion, thereby obtaining the mineralized particulate organic material. | 09-16-2010 |
20130090291 | HEMOSTATIC COMPOSITIONS - The invention discloses a hemostatic composition comprising: | 04-11-2013 |
20130096063 | HEMOSTATIC COMPOSITIONS - The invention discloses a hemostatic composition comprising: | 04-18-2013 |
20130096082 | HEMOSTATIC COMPOSITIONS - The invention discloses a hemostatic composition composing chitin or a water insoluble chitin derivative, especially water insoluble chitosan, in particulate form, wherein the composition is present in paste form. | 04-18-2013 |
20140161738 | HEMOSTATIC FOAM - The invention discloses a pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance and optionally a coagulation inducing agent, wherein albumin as foaming agent is present in native form; a method for the production of a transient hemostatic liquid foam; the transient hemostatic liquid foam; and a kit for making the foam. | 06-12-2014 |
20150314037 | HEMOSTATIC FOAM - The invention discloses a pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance and optionally a coagulation inducing agent, wherein albumin as foaming agent is present in native form; a method for the production of a transient hemostatic liquid foam; the transient hemostatic liquid foam; and a kit for making the foam. | 11-05-2015 |
Katarzyna Holc, Warszawa PL
Patent application number | Description | Published |
---|---|---|
20120147915 | LASER DIODE AND METHOD OF FABRICATION THE LASER DIODE - The laser diode is based on Al In Ga N alloy and consists of: a bottom cladding layer of n-type conductivity, a bottom waveguide layer of n-type conductivity, a light emitting layer, an electron blocking layer of p-type conductivity, an upper waveguide layer of p-type conductivity, an upper cladding layer of p-type conductivity and a subcontact layer, doped with acceptors with concentration level above 10 | 06-14-2012 |
Katarzyna Kaczorowska, Krakow PL
Patent application number | Description | Published |
---|---|---|
20090137811 | PROCESS FOR THE PREPARATION OF DONEPEZIL AND INTERMEDIATE COMPOUNDS THEREOF AS WELL AS HYDRATES OF DONEPEZIL - The present invention relates to a new process for the preparation of intermediate compounds useful in the manufacture of donepezil, or a pharmaceutically-acceptable salt thereof, and also relates to processes for preparing donepezil and to the novel intermediates per se. In addition the invention relates to various hydrated forms of donepezil. | 05-28-2009 |
Katarzyna Kaczorowska, Zagreb HR
Patent application number | Description | Published |
---|---|---|
20090298879 | Impurities of Donepezil - The present invention relates to impurities of donepezil, or a pharmaceutically acceptable salt thereof, which may be produced during synthesis and storage of donepezil, or a pharmaceutically-acceptable salt thereof, and to methods of identifying such impurities. The invention also relates to the use of these impurities in analytical techniques and to product that contain certain low levels of these impurities in particular the following impurities are disclosed: formula (I) and formula (II). | 12-03-2009 |
Katarzyna Kiec-Kononowicz, Krakow PL
Patent application number | Description | Published |
---|---|---|
20110028562 | DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE - The subject of the invention is a group of new derivatives of aminoalkaπols, more specifically [(phenoxy)alkyl]aminoalkanols and [(phenoxy)acyl)aminoalkanols, their method of obtaining and their use for production of a medicine which is used in the prophylaxis, prevention and/or treatment of diseases or symptoms having neurological background and for production of a medicine with anticonvulsant activity, which is used in seizures of various origin, also in the limbic system, in myoclonic or sound-induced seizures, in psychomotor epilepsy, as well as in relieving neuropathic or inflammatory pain. | 02-03-2011 |
20130289118 | DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE - The subject of the invention is a group of new derivatives of aminoalkanols, more specifically [(phenoxy)alkyl]aminoalkanols and [(phenoxy)acyl]aminoalkanols, their method of obtaining and their use for production of a medicine which is used in the prophylaxis, prevention and/or treatment of diseases or symptoms having neurological background and for production a medicine with anticonvulsant activity, which is used in seizures of various origin, also in the limbic system, in myoclonic or sound-induced seizures, in psychomotor epilepsy, as well as relieving neuropathic or inflammatory pain. | 10-31-2013 |
Katarzyna Komarowska, Alpharetta, GA US
Patent application number | Description | Published |
---|---|---|
20090277355 | ALKENYLSUCCINIC ANHYDRIDE SURFACE-APPLIED SYSTEM AND USES THEREOF - The invention relates to an aqueous sizing composition including: (a) a first component comprising an emulsion having an alkenylsuccinic anhydride component containing alkenylsuccinic anhydride particles and a surfactant component; suspended in water; and (b) a second component selected from the group consisting of cationic starches, non-ionic starches, anionic starches, water, water-soluble polymers, and mixtures thereof; such that the alkenylsuccinic anhydride component and the second component are sufficiently diluted to enable the sizing composition to impart useful sizing properties to a fibrous substrate when the sizing composition contacts the fibrous substrate. The invention also relates to fibrous substrates treated with such a composition as well as processes for making and using the composition. In one embodiment, alkyl ketene dimer is used instead of alkenylsuccinic anhydride. | 11-12-2009 |
Katarzyna Kublicka, Prezmierowo PL
Patent application number | Description | Published |
---|---|---|
20140004232 | NANOIRON-BASED OXYGEN SCAVENGERS | 01-02-2014 |
Katarzyna Kucwaj, Krakow PL
Patent application number | Description | Published |
---|---|---|
20150274726 | SUBSTITUTED TRICYCLIC BENZIMIDAZOLES AS KINASE INHIBITORS - Disclosed are substituted tricyclic benzimidazoles compounds as defined herein in formula (I) or pharmaceutically acceptable salts thereof. The compounds of the invention selectively inhibit CDK8 and are therefore useful for treating diseases related to this kinase, especially colorectal and melanoma cancers and other solid and hemathological malignancies, autoimmune diseases and inflammatory diseases. Also disclosed are processes for preparing these compounds. | 10-01-2015 |
Katarzyna Kudlaty, Gossendorf AT
Patent application number | Description | Published |
---|---|---|
20140216161 | CAPACITIVE ULTRASONIC TRANSDUCER - The invention relates to capacitive ultrasonic transducer comprising a sensor head having a back plate, the structured front side of which is provided with an insulation layer, and. the back side of which is provided with an electrode. | 08-07-2014 |
20140216166 | METHOD FOR DETERMINING THE FLOW RATE OF FLUIDS USING THE ULTRASONIC TRANSIT TIME METHOD - In a method for determining the flow rate of fluids using the ultrasonic transit time method, the flow speed and therefrom the flow rate of the fluid is determined from the transit time of ultrasound signals through the measurement section. | 08-07-2014 |
Katarzyna Kurzepa, Warka PL
Patent application number | Description | Published |
---|---|---|
20100047196 | NOVEL MICROSTRUCTURAL PROTEIN PREPARATIONS CONTAINING ADSORBED BIOLOGICALLY ACTIVE SUBSTANCES AND THEIR APPLICATION IN MEDICINE AND COSMETICS - Protein preparations containing biologically active compounds and the application of the protein preparations obtained, particularly as a component of medicinal and cosmetic preparations as protective substances or in the regeneration of cells and tissues of the human organism, and which can comprise a component of culture media for dermal or hepatic tissues, or for stem cells destined for use in the regeneration of cells and tissues in the human organism. | 02-25-2010 |
Katarzyna Leijten-Nowak, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20080288909 | Template-Based Domain-Specific Reconfigurable Logic - A method is provided which creates an architecture of a reconfigurable logic core. The architecture can be deployed for various purposes and its implementation is costefficient in terms of area, performance and power. The invention relies on the perception that a template can be used to describe such an architecture. The architecture can then easily be created as an instance of the template. The template is a model which defines logic components, routing components and interface components of a reconfigurable logic core. For example, logic components may be logic elements, processing elements, logic blocks, logic tiles and arrays in a hierarchical order. Routing components may comprise routing channels comprising routing tracks which provide interconnection means between the logic components. Interface components may be input and output ports. The model is configured by a number of parameters; the value of these parameters is in accordance with an application domain. | 11-20-2008 |
Katarzyna Lubelska, Warszawa PL
Patent application number | Description | Published |
---|---|---|
20150266888 | DERIVATIVES OF CAMPTOTHECIN, A METHOD OF PRODUCING THEM AND THEIR USE - The subject of the present invention are water-soluble derivatives of camptothecin, their synthesis and use. These compounds exhibit preferable biological properties for use in anti-neoplasm therapy. | 09-24-2015 |
Katarzyna Maresz, Milwaukee, WI US
Patent application number | Description | Published |
---|---|---|
20100021428 | Use Of Gelsolin To Treat Multiple Sclerosis And To Diagnose Neurologic Disease (Stossel) - The invention relates to the use of gelsolin to treat neurologic diseases (e.g., multiple sclerosis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of neurologic diseases. | 01-28-2010 |
20130230455 | USE OF GELSOLIN TO TREAT MULTIPLE SCLEROSIS AND TO DIAGNOSE NEUROLOGIC DISEASES - The invention relates to the use of gelsolin to treat neurologic diseases (e.g., multiple sclerosis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of neurologic diseases. | 09-05-2013 |
Katarzyna Myhan, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20160063646 | System and Method for Controlling Access to Member Content in a Dating Website - The dating website disclosed can comprise a server memory and a server processor. The server memory can store a dating website and a plurality of profiles. The profiles can comprise standard profile data, premium profile data having purchasable content and non-purchasable content, and a permission status. The server processor can, according to instructions from the dating website provide access to the standard profile data within the profiles of the dating website. The server processor can further offer for sale access to each of the purchasable content, each of the purchasable content comprising a content identifier. The processor can store the content identifier on the permission status of a purchaser's profile when the member buys the purchasable content of a second member. The server processor can provide access to the purchasable content associated with the content identifier within the permission status to the member associated with the permission status. | 03-03-2016 |
20160063647 | System and Method for Providing Access to Member Content of a Dating Website to a Third Party Dating Website Provider - The disclosure teaches a system and method for providing access to member content of a dating website to a third party dating website provider. The dating website content host system can comprise a server memory and a server processor. The server memory can store a dating website and one or more service provider accounts. Each of the service provider accounts can comprise one or more purchasable content packages, and an account permission status. The purchasable content packages can comprise one or more purchasable contents. Each of the purchasable content can comprise a content identifier. | 03-03-2016 |
Katarzyna Niespodziana, Vienna AT
Patent application number | Description | Published |
---|---|---|
20120213820 | Pharmaceutical composition for the treatment and prevention of a rhinovirus infection - The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4. | 08-23-2012 |
20140193450 | PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES - The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide. | 07-10-2014 |
20150335735 | PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES - The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide. | 11-26-2015 |
Katarzyna Olas, Vienna AT
Patent application number | Description | Published |
---|---|---|
20090221017 | ANTI-AMYLOID BETA ACTIVITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN VITRO - The present invention relates to a cell-based in vitro screening assay for identifying and selecting therapeutic agents that inhibit amyloid r-induced cytotoxicity. | 09-03-2009 |
Katarzyna Pels, Luzna PL
Patent application number | Description | Published |
---|---|---|
20160060631 | DNA APTAMERS BINDING THE HISTIDINE TAG AND THEIR APPLICATION - A DNA aptamer was obtained which has an affinity for His-tag, and contains a nucleotide sequence selected from SEQ ID No. 1 and SEQ ID No. 2, which has clear applications. | 03-03-2016 |
Katarzyna Pieta, Lodz PL
Patent application number | Description | Published |
---|---|---|
20100137576 | 5' O [(N ACYL)AMIDOPHOSPHATE] AND 5' O [(N ACYL)AMIDOTHIOPHOSPHATE] AND 5' O [(N ACYL)AMIDODITHIOPHOSPHATE] AND 5' O [(N ACYL)AMIDOSELENOPHOSPHATE] DERIVATIVES OF NUCLEOSIDES AND PROCESSES FOR THE MANUFACTURE THEREOF - The subject of the invention includes 5′-O-[(N-acyl)amidophosphate]- and 5′-O-[(N-acyl)amidothiophosphate]- and 5′-O-[(N-acyl)amidodithiophosphate]- and 5′-O-[(N-acyl)amidoselenophosphate]- derivatives of nucleosides. | 06-03-2010 |
Katarzyna Plonska-Ocypa, Warsaw PL
Patent application number | Description | Published |
---|---|---|
20090186950 | 13,13-Dimethyl-des-C,D Analogs of 1Alpha,25-Dihydroxy-19-Nor-Vitamin D3 Compounds and Topical Composition Dosage Forms and Methods of Treating Skin Conditions Thereof - 13,13-Dimethyl-des-C,D analogs of 1α,25-dihydroxy-19-nor-vitamin D | 07-23-2009 |
20110082121 | 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 1-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-1-desoxy-2-methylene-19-nor-vitamin D | 04-07-2011 |
20120157418 | 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-2-methylene-19-nor-vitamin D | 06-21-2012 |
Katarzyna Radecka, Verdun CA
Patent application number | Description | Published |
---|---|---|
20160001131 | Accurate Step Counting Pedometer for Children, Adults and Elderly - The present invention related to the area of lifestyle devices, particularly to pedometers used for exercise tracking. This invention aims at accurate recording of steps, speeds, distances, type of motion (walk and run) and calories expenditure, independently of the personal characteristics (age, gender, weight and height). The invention uses sub-band decomposition filters that produce non-distorted sine wave regardless of personal traits and the type of walking or running. Low-complexity zero-crossing step detection is subsequently applied, and the step length and energy expenditure information is then extracted. The method for goals tracking is included for independent types of goals: steps, energy, distance and duration. | 01-07-2016 |
Katarzyna Sidoryk, Warszawa PL
Patent application number | Description | Published |
---|---|---|
20080234493 | Process for the Preparation of 2-[N-[{S)-1-Ethoxycarbonyl-3-Phenylpropyl]-(S)-Alanyl]-(1S,3S,5S)-2-Azabicyclo[3.3.0]Oct- an-3-Carboxylic Acid - A process for preparation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-(S)-alanyl]-(1S,3S,5S)-2- azabicyclo [3.3.0] octane-3-carboxylic acid, ie. Ramipril, involves condensation of an activated derivative of 2-[N-](S)-1-ethoxycarbonyl-3-phenylpropyl]-(S)-alanine with racemic (1R*,3R*,5R*)-2-azabicyclo[3.3.0]octane-3-carboxylic acid, and then the desired diastereoisomer (1a) is separated from the obtained diastereoisomeric mixture of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl](S)-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (1a) and 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl -alanyl]-(1R,3R,5R)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (1b) by treating it with a solvent that selectively dissolves the undesired diastereoisomer (1b) while the diastereoisomer (1a) remains undissolved. | 09-25-2008 |
Katarzyna Sobecka, Szczecin PL
Patent application number | Description | Published |
---|---|---|
20140138320 | AGENT FOR REMOVING PHOSPHORUS COMPOUNDS FROM WATER - Agent for removing dissolved phosphorus compounds from water according to the invention, containing a biopolymer and metal compound, is characterized by being in the form of spherical capsules which contain the biopolymer or derivatives thereof with the ionic character crosslinked in the presence of at least one water-soluble polyvalent metal compounds. | 05-22-2014 |
20140141243 | METHOD OF PRODUCING AGENT FOR REMOVING DISSOLVED PHOSPHORUS COMPOUNDS FROM WATER AND AGENT FOR REMOVING DISSOLVED PHOSPHORUS COMPOUNDS FROM WATER - A method for the producing of an agent for the removal of dissolved phosphorus compounds from water, relying on the formation of the biopolymer metal compound system which is characterized by that, the natural plant fibres are subjected to the activation, subsequently the activated natural plant fibres are coated with biopolymer or derivatives thereof with the ionic character. The natural plant fibres are coated with at least one water-soluble polyvalent metal compound before or after coating the natural plant fibres with biopolymer or derivatives thereof with the ionic character. Such modified natural plant fibres form a composite fibrous material in the form of biopolymer hydrogel support crosslinked in the presence of water-soluble polyvalent metal compound support on the warp from natural fibre. | 05-22-2014 |
Katarzyna Sokolowska, Lomza PL
Patent application number | Description | Published |
---|---|---|
20100009944 | 19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring - 19-nor-vitamin D analogs having an additional dihydrofuran ring connecting the 1α-oxygen and carbon-2 of the A-ring of the analog, and pharmaceutical uses therefore, are described. These compounds exhibit selective in vitro and in vivo activities, making them therapeutic agents for the treatment or prophylaxis of autoimmune diseases, some types of cancers, secondary hyperparathyroidism, psoriasis, or other skin diseases. | 01-14-2010 |
20100009945 | 19-NOR-VITAMIN D ANALOGS WITH 3,2-DIHYDROFURAN RING - 19-nor-vitamin D analogs having an additional dihydrofuran ring connecting the 3β-oxygen and carbon-2 of the A-ring of the analog, and pharmaceutical uses therefore, are described. These compounds exhibit selective in vitro and in vivo activities, making them therapeutic agents for the treatment or prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases. | 01-14-2010 |
20110082123 | 6-Methylvitamin D3 Analogs and Their Uses - This invention discloses 6-methylvitamin D | 04-07-2011 |
Katarzyna Szczaurska, Kluczbork PL
Patent application number | Description | Published |
---|---|---|
20090264510 | Double helical oligonucleotides interfering with mRNA used as effective anticancer agents - The present invention relates to the application of double-helical oligonucleotides (siRNA) interfering with the mRNA of gene involved in carcinogenesis, particularly the Wnt1, Wnt2 or Her3 genes. Such oligonucleotides may be modified chemically, used in conjunction with viral and non-viral vectors such as lipid complexes. Such oligonucleotides exhibit unusual anti-proliferative properties against tumour cells and may be used in anti-tumour treatment. | 10-22-2009 |
Katarzyna Wiklik, Krakow PL
Patent application number | Description | Published |
---|---|---|
20150274726 | SUBSTITUTED TRICYCLIC BENZIMIDAZOLES AS KINASE INHIBITORS - Disclosed are substituted tricyclic benzimidazoles compounds as defined herein in formula (I) or pharmaceutically acceptable salts thereof. The compounds of the invention selectively inhibit CDK8 and are therefore useful for treating diseases related to this kinase, especially colorectal and melanoma cancers and other solid and hemathological malignancies, autoimmune diseases and inflammatory diseases. Also disclosed are processes for preparing these compounds. | 10-01-2015 |
20150336967 | Novel Benzimidazole Derivatives as Kinase Inhibitors - The present invention relates to derivatives of benzimidazoles of formula (I) as disclosed herein as well as pharmaceutical compositions comprising said derivatives. The derivates according to the present invention are serine/threonine and tyrosine kinase-inhibitors, particularly of PIM1-3- and DYRK1A-kinases and may particularly be used in the treatment of diseases linked to these kinases, such as e.g. leukemias, lymphomas, solid tumors and autoimmune disorders. | 11-26-2015 |
Katarzyna Wiktorska, Warszawa PL
Patent application number | Description | Published |
---|---|---|
20150266888 | DERIVATIVES OF CAMPTOTHECIN, A METHOD OF PRODUCING THEM AND THEIR USE - The subject of the present invention are water-soluble derivatives of camptothecin, their synthesis and use. These compounds exhibit preferable biological properties for use in anti-neoplasm therapy. | 09-24-2015 |
Katarzyna Zagajska, Radom PL
Patent application number | Description | Published |
---|---|---|
20140097107 | Modular multi-segment tray, carrying element and modular tray insert - The object of the application is a modular multi-segment tray ( | 04-10-2014 |
Katarzyna Zientara-Rytter, Wiazowna PL
Patent application number | Description | Published |
---|---|---|
20140259214 | PLANT HOMOLOG TO AUTOPHAGY PROTEIN P62 - The present invention comprises recombinant DNA molecule, expression cassette, DNA vector, binary plasmid, plant cell and a method of polypeptide production in eukaryotic organism and use thereof. In more details, it provides the means, through using methods of genetic engineering, of obtaining plants with advantageous breeding features, particularly with increased tolerance to abiotic stresses including mineral deficiency or plants useful for monitoring the process of autophagy. | 09-11-2014 |